Marianne De Backer
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vir Biotechnology, Inc. (VIR) | M.Sc., Ph.D., MBA President, Chief Executive Officer and Director | $950,000 | $7,834,045 |
| 2024 | Vir Biotechnology, Inc. (VIR) | M.Sc., Ph.D., MBA Chief Executive Officer and Director | $920,833 | $9,255,903 |
| 2023 | Vir Biotechnology, Inc. (VIR) | M.Sc., Ph.D., MBA Chief Executive Officer and Director | $675,000 | $39,491,495 |
Earnings-call appearances
-
Vir Biotechnology Second Quarter 2026 Corporate Update and Financial Results Conference Call2026-08-05
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q1 FY2026 Earnings Call2026-05-06
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q4 FY2025 Earnings Call2026-02-23
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q3 FY2025 Earnings Call2025-11-05
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q2 FY2025 Earnings Call2025-08-06
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q1 FY2025 Earnings Call2025-05-07
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q4 FY2024 Earnings Call2025-02-26
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q3 FY2024 Earnings Call2024-10-31
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q2 FY2024 Earnings Call2024-08-01
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q1 FY2024 Earnings Call2024-05-02
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q4 FY2023 Earnings Call2024-02-22
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q3 FY2023 Earnings Call2023-11-02
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q2 FY2023 Earnings Call2023-08-03
Vir Biotechnology, Inc. (VIR)